1. Concentration-controlled compared with conventional antiretroviral therapy for HIV infection;Fletcher;AIDS,2002
2. Long-term efficacy and safety of ritonavir/indinavir at 400/400mg twice a day in combination with two nucleoside reverse transcriptase inhibitors as first line antiretroviral therapy;Lichterfeld;HIV Med,2002
3. HIV-1 genotype and phenotype correlate with virological response to abacavir, amprenavir and efavirenz in treatment-experienced patients;Falloon;AIDS,2002
4. Nucleoside-analogue reverse-transcriptase inhibitors plus nevirapine, nelfinavir, or ritonavir for pretreated children infected with human immunodeficiency virus type 1;Krogstad;Clin Infect Dis,2002
5. Quality of life, emotional status, and adherence of HIV-1-infected patients treated with efavirenz versus protease inhibitor-containing regimens;Fumaz;J Acquir Immune Defic Syndr,2002